StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Novartis Pharmaceuticals UK Ltd by Year

Novartis Pharmaceuticals UK Ltd — Median Gender Bonus Gap (%) (%)

Novartis Novartis Pharmaceuticals UK Ltd: 29.3% in FY2025, up 0.1 pts from a year earlier. That is the highest of the 9 years on record here.

Latest, FY2025
29.3%
Period ended Dec 31, 2025
Change on a year earlier
+0.1 pts
29.2% in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

“NOVARTIS PHARMACEUTICALS UK LIMITED (00119006, 2025, size 1000 to 4999) — DiffMedianBonusPercent: 29.3%”

Source: UK Government Gender Pay Gap Service — Statutory Filing (2025) ↗

Reported in UK Government Gender Pay Gap Service.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Novartis Novartis Pharmaceuticals UK Ltd (%), annual FY2017–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/sub-uk-median-bonus-gap-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.